CHAD PERRY: Open Payments
NPI 1508980947 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,973 in 204 payments from 18 companies in 2025. Trend: 2023 $4,272 · 2024 $10,870 · 2025 $4,973
Food & beverage: $4,873Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $1,066 |
| Janssen Biotech, Inc. | 32 | $893 |
| Regeneron Healthcare Solutions, Inc. | 25 | $735 |
| GENZYME CORPORATION | 14 | $513 |
| Novartis Pharmaceuticals Corporation | 13 | $377 |
| Incyte Corporation | 16 | $346 |
| UCB, Inc. | 20 | $335 |
| Lilly USA, LLC | 10 | $242 |
| REVANCE THERAPEUTICS, INC. | 1 | $143 |
| Galderma Laboratories, L.P. | 3 | $110 |
Products named: DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, Bimzelx, OPZELURA, COSENTYX, Rhapsido.
Industry payments across GA — which companies pay providers there.
